Stocks Telegraph

ANIP Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:ANIP

ANI Pharmaceuticals, Inc.

$56.15
1.83+3.37%
At Close 4:00 PM
58.84
BESG ScoreESG Rating

ANIP FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ANIP Income Statement


A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
revenue138.04M137.43M131.654M131.829M116.547M
cost of revenue72.395M63.843M68.614M48.101M42.284M
gross profit65.645M73.587M63.04M83.728M74.263M
gross profit ratio0.4760.5350.4790.6350.637
research and development expenses7.296M10.511M9.867M11.121M7.374M
general and administrative expenses00000
selling and marketing expenses00000
selling general and administrative expenses52.821M48.021M44.462M42.007M38.76M
other expenses-88.00K-32.00K-33.00K-39.00K-53.00K
operating expenses60.117M58.532M54.329M68.335M60.824M
cost and expenses132.512M122.375M122.943M116.436M103.108M
interest income0006.398M7.10M
interest expense4.656M4.60M5.589M6.398M7.10M
depreciation and amortization14.697M14.686M15.194M15.207M14.69M
ebitda20.225M29.741M23.905M30.561M28.076M
ebitda ratio0.1470.2160.1820.2320.241
operating income5.528M15.055M8.711M17.948M12.402M
operating income ratio0.040.110.0660.1360.106
total other income expenses net-7.815M10.28M-7.764M2.516M-1.09M
income before tax-2.287M25.335M947.00K11.511M5.249M
income before tax ratio-0.0170.1840.0070.0870.045
income tax expense07.128M-208.00K1.571M-996.00K
net income-2.287M18.207M1.155M9.94M6.245M
net income ratio-0.0170.1320.0090.0750.054
eps-0.120.840.0390.500.33
eps diluted-0.120.830.0390.500.33
weighted average shs out19.321M19.099M19.003M18.883M17.688M
weighted average shs out dil19.321M19.422M19.219M19.125M17.855M
Graph

ANIP Balance Sheet


Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
cash and cash equivalents240.11M228.597M221.121M193.078M161.707M
short term investments6.943M9.655M000
cash and short term investments247.053M238.252M221.121M193.078M161.707M
net receivables166.091M172.418M162.079M178.842M172.925M
inventory125.448M113.837M111.196M106.59M104.323M
other current assets16.568M16.05M25.22M10.69M8.248M
total current assets555.16M540.557M519.616M497.22M459.311M
property plant equipment net51.64M48.526M44.593M44.189M44.371M
goodwill28.221M28.221M28.221M28.221M28.221M
intangible assets183.078M196.044M209.009M219.828M230.299M
goodwill and intangible assets211.299M224.265M237.23M248.049M258.52M
long term investments7.40M7.70M010.00M9.174M
tax assets89.506M87.607M90.711M84.389M81.50M
other non current assets5.748M5.869M12.272M6.067M6.465M
total non current assets365.593M373.967M384.806M392.694M400.03M
other assets00000
total assets920.753M914.524M904.422M889.914M859.341M
account payables48.681M49.43M36.683M34.077M28.505M
short term debt850.00K850.00K850.00K850.00K850.00K
tax payables2.867M11.402M8.164M594.00K4.088M
deferred revenue2.867M11.402M8.164M75.486M4.088M
other current liabilities87.58M75.207M99.78M23.939M89.422M
total current liabilities139.978M136.889M145.477M134.352M122.865M
long term debt309.244M309.457M309.669M285.032M285.244M
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities15.771M16.215M16.527M15.819M16.76M
total non current liabilities325.015M325.672M326.196M300.851M302.004M
other liabilities01.00000
capital lease obligations4.679M5.055M4.809M00
total liabilities464.993M462.561M471.673M435.203M424.869M
preferred stock24.85M24.85M24.85M24.85M24.85M
common stock2.00K2.00K2.00K2.00K2.00K
retained earnings-65.025M-62.331M-80.132M-80.88M-90.414M
accumulated other comprehensive income loss8.328M9.406M8.857M14.076M13.726M
other total stockholders equity487.605M480.036M479.172M496.663M486.308M
total stockholders equity455.76M451.963M432.749M454.711M434.472M
total equity455.76M451.963M432.749M454.711M434.472M
total liabilities and stockholders equity920.753M914.524M904.422M889.914M859.341M
minority interest00000
total investments6.943M9.655M010.00M9.174M
total debt310.094M310.307M315.328M285.882M286.094M
net debt69.984M81.71M94.207M92.804M124.387M
Graph

ANIP Cash Flow


A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax-1.899M3.104M-8.346M-3.257M-910.00K
stock based compensation7.864M6.934M5.621M5.444M5.249M
change in working capital-4.505M-10.225M27.798M5.566M-6.73M
accounts receivables6.327M-10.339M16.763M-5.918M1.789M
inventory-11.611M-2.641M-4.605M-2.268M-669.00K
accounts payables-1.147M11.526M2.78M5.572M-3.905M
other working capital1.926M-8.771M12.86M8.18M-3.945M
other non cash items47.233M25.128M3.318M-731.00K2.082M
net cash provided by operating activities17.414M18.269M44.74M32.169M20.626M
investments in property plant and equipment-4.449M-4.581M-4.779M-4.553M-6.826M
acquisitions net013.514M000
purchases of investments00000
sales maturities of investments00000
other investing activites07.711M000
net cash used for investing activites-4.449M8.933M-4.779M-4.553M-6.826M
debt repayment-750.00K-750.00K-750.00K-750.00K-750.00K
common stock issued1.005M2.591M1.969M5.581M81.844M
common stock repurchased-1.30M-8.661M-231.00K-670.00K-537.00K
dividends paid-407.00K-406.00K-406.00K-406.00K-407.00K
other financing activites1.005M-12.50M-12.50M4.161M80.557M
net cash used provided by financing activities-1.452M-19.726M-11.918M3.755M80.15M
effect of forex changes on cash00-6.479M0-80.186M
net change in cash11.513M7.476M28.043M31.371M93.95M
cash at end of period240.11M228.597M221.121M193.078M161.707M
cash at beginning of period228.597M221.121M193.078M161.707M67.757M
operating cashflow17.414M18.269M44.74M32.169M20.626M
capital expenditure-4.449M-4.581M-4.779M-4.553M-6.826M
free cash flow12.965M13.688M39.961M27.616M13.80M
Graph

Frequently Asked Questions

How did ANI Pharmaceuticals, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ANIP generated $138.04M in revenue last quarter, while its costs came in at $72.40M.

Last quarter, how much Gross Profit did ANI Pharmaceuticals, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. ANI Pharmaceuticals, Inc. reported a $65.65M Gross Profit for the quarter ended Jun 30, 2024.

Have ANIP's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ANIP incurred $60.12M worth of Operating Expenses, while it generated $5.53M worth of Operating Income.

How much Net Income has ANIP posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from ANI Pharmaceuticals, Inc., the company generated -$2.29M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did ANI Pharmaceuticals, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to ANI Pharmaceuticals, Inc. as of the end of the last quarter was $240.11M.

What are ANIP's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ANIP had Total Net Receivables of $166.09M.

In terms of Total Assets and Current Assets, where did ANI Pharmaceuticals, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ANIP were $555.16M, while the Total Assets stand at $920.75M.

As of the last quarter, how much Total Debt did ANI Pharmaceuticals, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ANIP's debt was $310.09M at the end of the last quarter.

What were ANIP's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ANIP reported total liabilities of $464.99M.

How much did ANIP's Working Capital change over the last quarter?

Working Capital Change for ANIP was -$4.51M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

ANIP generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ANIP generated $17.41M of Cash from Operating Activities during its recently reported quarter.

What was ANIP's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ANIP reported a $11.51M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Login Form

OR
stockstelegraph

Join to access AI-powered insights from top Wall Street analysts.

Signup Form

OR
stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Reset Password Form

stockstelegraph

Subscribe to gain access to powerful insights powered by AI and Wallstreet analysts.

This feature is only available to Premium Users.

Subscribe Now